This study is to evaluate whether intraoperative fluorescence imaging targeting GPC3 can aid improve the surgical accuracy of hepatocellular carcinoma. The main purposes of this study include: ① To raise the detection rate of hepatocellular carcinoma intraoperatively using the novel NIR-II fluorescence molecular imaging and the GPC-3 targeted fluorophore. ② To validate the safety and effectiveness of the designed GPC-3 targeted fluorophore for clinical application.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
60
Drug Injection: Anti-GPC3-IRDye800CW
Zhuhai People's Hospital
Zhuhai, Guangdong, China
RECRUITINGThe Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China
RECRUITINGHCC lesions
Numbers of intraoperatively detected hepatocellular carcinoma lesions.
Time frame: During hepatocellular resection surgery.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.